Delivery Order SPE2DB24D2205-SPE2DB24FDWPC

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $3,881.87 delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. This contract is a firm fixed price, delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC serves as...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,088.07 delivery order is under a larger, single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which expires on December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The $4,067.19 firm fixed price contract was awarded by the Medical Supply Chain division of the Department of Defense. The contract has an ultimate completion date of July 12, 2024 and was awarded on July 11, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,988.96 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of June 12, 2024. This Delivery Order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA,...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to the U.S. government. The award, valued at $33,413.79, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) worth up to...
This federal contract award is a delivery order worth $1,402.59 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for AIMOVIG 70 MG/ML AUTOINJECTORML, a specialty medication, with a period of performance through November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML with a firm fixed price of $4,611.36. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC encompasses a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $2,002.32 to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The contract, valued at $1,050.38, is a firm-fixed price delivery order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWPC
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products. The $2,567.03 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a wide range of pharmaceutical and medical supplies to DLA facilities supporting the Department of Defense globally. This specific delivery order falls under that larger IDC. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 10/8/24, 9:16 AM